The relationship between multiple sclerosis and vitamin D runs in both directions, but the stronger evidence points to low vitamin D as a risk factor for developing MS, not primarily the other way around. That said, once you have MS, the disease itself can make it harder to maintain healthy vitamin D levels through several overlapping mechanisms.
What Genetic Studies Reveal About the Direction
The most powerful tool researchers have for untangling cause and effect is a technique called Mendelian randomization, which uses genetic variants as a kind of natural experiment. A large-scale study using 115 genetic variants linked to vitamin D levels found that as genetically determined vitamin D levels increased, the risk of MS decreased significantly. People with genetic profiles associated with higher vitamin D had roughly half the risk of developing MS compared to those with lower levels. This strongly suggests that low vitamin D contributes to MS risk, rather than MS simply dragging vitamin D levels down.
That finding doesn’t rule out the reverse, though. Once MS is established, the disease creates conditions that genuinely lower vitamin D.
How MS Pushes Vitamin D Levels Down
Several features of living with MS work against maintaining adequate vitamin D. The most straightforward is reduced sun exposure. Many people with MS are sensitive to heat, which can temporarily worsen neurological symptoms. This leads to avoiding time outdoors, especially in warm weather, which is exactly when your skin would produce the most vitamin D from sunlight. People with limited mobility, particularly those who are partially or fully dependent on a wheelchair, get even less sun exposure.
Beyond lifestyle factors, there appears to be something happening at a biological level. Research published in JCI Insight found that when MS patients and healthy volunteers took the same dose of oral vitamin D supplements, the MS group had a smaller rise in blood levels. Even after accounting for that difference, the metabolic effects of supplementation were blunted in the MS group. The researchers described this as a “resistance to the metabolic effects of vitamin D” that may be driven by the chronic inflammation characteristic of MS. In other words, the disease may interfere with how your body processes and uses vitamin D, not just how much you take in.
How Common Is Vitamin D Deficiency in MS?
Vitamin D deficiency is extremely common in people with MS, though it’s also widespread in the general population. One study comparing MS patients, their siblings, and unrelated healthy controls found deficiency rates of about 87% in the MS group, 84% in siblings, and 93% in healthy controls. Those numbers are striking because the healthy group actually had the highest deficiency rate, which likely reflects how common vitamin D deficiency is across the board, particularly in populations with limited sun exposure. The takeaway isn’t that MS uniquely causes deficiency but that nearly everyone in these groups was deficient, and people with MS have additional reasons to stay that way.
Why Vitamin D Levels Matter After Diagnosis
Regardless of which came first, vitamin D levels have a measurable relationship with how MS behaves over time. A study published in JAMA Neurology tracked patients after their first MS-like episode and found that a 20 ng/mL increase in average vitamin D levels during the first year predicted 57% fewer new brain lesions and a 57% lower relapse rate over the following four years. Higher early vitamin D levels also predicted slower accumulation of lesion volume and less brain tissue loss. Patients whose levels reached at least 20 ng/mL within the first 12 months had lower disability scores over the next four years.
These are observational findings, so they don’t prove supplementation alone drives those improvements. But the pattern is consistent and the effect sizes are large enough to have shaped clinical thinking about vitamin D management in MS.
Target Levels and Supplementation
The general population target for vitamin D is typically around 30 ng/mL. For people with MS, many clinicians aim higher. A 2025 review in the Journal of the Neurological Sciences recommended maintaining blood levels between 40 and 60 ng/mL year-round, measured at least annually. That range is intended to support immune function beyond just bone health, though the authors noted that definitive studies linking those specific targets to better MS outcomes are still limited.
Common supplementation doses for people with MS fall between 1,000 and 4,000 IU of vitamin D3 daily, a range the U.S. Department of Veterans Affairs describes as very unlikely to cause toxicity. Because MS patients may absorb and respond to vitamin D less efficiently than healthy individuals, periodic blood testing matters more than simply taking a standard dose and assuming it’s enough. Your actual blood level, not just the dose you take, is what determines whether supplementation is working.
The Full Picture
The best available evidence suggests low vitamin D is primarily a contributor to MS risk rather than a consequence of it. But the relationship isn’t purely one-directional. MS creates real barriers to maintaining vitamin D through heat sensitivity, reduced mobility, and what appears to be a biological resistance to vitamin D’s effects driven by chronic inflammation. The practical result is a cycle: low vitamin D raises MS risk, and having MS makes it harder to correct the deficiency. Breaking that cycle with adequate supplementation and regular monitoring of blood levels is one of the more straightforward steps available to people managing the disease.